• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本北陆地区家族性高胆固醇血症纯合子的分子遗传流行病学研究。

Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan.

机构信息

Department of Lipidology, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.

出版信息

Atherosclerosis. 2011 Feb;214(2):404-7. doi: 10.1016/j.atherosclerosis.2010.11.005. Epub 2010 Nov 13.

DOI:10.1016/j.atherosclerosis.2010.11.005
PMID:21146822
Abstract

AIM

Familial hypercholesterolemia (FH) is caused by mutations of FH genes, i.e. LDL-receptor (LDLR), PCSK9 and apolipoprotein B (ApoB) gene. We evaluated the usefulness of DNA analysis for the diagnosis of homozygous FH (homo-FH), and studied the frequency of FH in the Hokuriku district of Japan.

METHODS

Twenty-five homo-FH patients were recruited. LDLR mutations were identified using the Invader assay method. Mutations in PCSK9 were detected by PCR-SSCP followed by direct sequence analysis.

RESULTS

We confirmed 15 true homozygotes and 10 compound heterozygotes for LDLR mutations. Three types of double heterozygotes for LDLR and PCSK9 were found. No FH patients due to ApoB mutations were found. The incidences of homo-FH and hetero-FH in the Hokuriku district were 1/171,167 and 1/208, respectively.

CONCLUSIONS

Our observations underlined the value of FH gene analysis in diagnosing homo-FH and confirmed extraordinarily high frequency of FH in the Hokuriku district of Japan.

摘要

目的

家族性高胆固醇血症(FH)是由 FH 基因,即 LDL 受体(LDLR)、前蛋白转化酶枯草溶菌素 9(PCSK9)和载脂蛋白 B(ApoB)基因突变引起的。我们评估了 DNA 分析在诊断纯合子家族性高胆固醇血症(homo-FH)中的作用,并研究了日本北陆地区 FH 的频率。

方法

招募了 25 名 homo-FH 患者。使用 Invader 检测方法鉴定 LDLR 突变。通过 PCR-SSCP 检测 PCSK9 突变,然后直接进行序列分析。

结果

我们证实了 15 例 LDLR 突变的真正纯合子和 10 例复合杂合子。发现了 3 种 LDLR 和 PCSK9 的双杂合子。未发现 ApoB 突变导致的 FH 患者。北陆地区 homo-FH 和 hetero-FH 的发病率分别为 1/171167 和 1/208。

结论

我们的观察结果强调了 FH 基因分析在诊断 homo-FH 中的价值,并证实了日本北陆地区 FH 的极高发病率。

相似文献

1
Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan.日本北陆地区家族性高胆固醇血症纯合子的分子遗传流行病学研究。
Atherosclerosis. 2011 Feb;214(2):404-7. doi: 10.1016/j.atherosclerosis.2010.11.005. Epub 2010 Nov 13.
2
Genotypic and phenotypic features in homozygous familial hypercholesterolemia caused by proprotein convertase subtilisin/kexin type 9 (PCSK9) gain-of-function mutation.由前蛋白转化酶枯草杆菌蛋白酶/kexin 9型(PCSK9)功能获得性突变引起的纯合子家族性高胆固醇血症的基因型和表型特征。
Atherosclerosis. 2014 Sep;236(1):54-61. doi: 10.1016/j.atherosclerosis.2014.06.005. Epub 2014 Jun 26.
3
Spectrum of mutations in homozygous familial hypercholesterolemia in India, with four novel mutations.印度纯合子家族性高胆固醇血症的突变谱,包含四种新突变。
Atherosclerosis. 2016 Dec;255:31-36. doi: 10.1016/j.atherosclerosis.2016.10.028. Epub 2016 Oct 14.
4
The genetic spectrum of familial hypercholesterolemia in the central south region of China.中国中南地区家族性高胆固醇血症的基因谱
Atherosclerosis. 2017 Mar;258:84-88. doi: 10.1016/j.atherosclerosis.2017.02.007. Epub 2017 Feb 11.
5
Molecular genetics of familial hypercholesterolemia in Israel-revisited.以色列家族性高胆固醇血症的分子遗传学研究回顾。
Atherosclerosis. 2017 Feb;257:55-63. doi: 10.1016/j.atherosclerosis.2016.12.021. Epub 2016 Dec 18.
6
Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia.德国家族性高胆固醇血症患者的临床特征及突变谱。
Atherosclerosis. 2016 Oct;253:88-93. doi: 10.1016/j.atherosclerosis.2016.08.037. Epub 2016 Aug 26.
7
The E32K variant of PCSK9 exacerbates the phenotype of familial hypercholesterolaemia by increasing PCSK9 function and concentration in the circulation.PCSK9 的 E32K 变异通过增加 PCSK9 在循环中的功能和浓度,加重家族性高胆固醇血症的表型。
Atherosclerosis. 2010 May;210(1):166-72. doi: 10.1016/j.atherosclerosis.2009.11.018. Epub 2009 Nov 20.
8
Molecular characterization of familial hypercholesterolemia in Spain.西班牙家族性高胆固醇血症的分子特征。
Atherosclerosis. 2012 Mar;221(1):137-42. doi: 10.1016/j.atherosclerosis.2011.12.021. Epub 2011 Dec 23.
9
Genetic analysis of familial hypercholesterolaemia in Western Australia.澳大利亚西部家族性高胆固醇血症的遗传学分析。
Atherosclerosis. 2012 Oct;224(2):430-4. doi: 10.1016/j.atherosclerosis.2012.07.030. Epub 2012 Jul 27.
10
Effect of mutations in LDLR and PCSK9 genes on phenotypic variability in Tunisian familial hypercholesterolemia patients.LDLR 和 PCSK9 基因突变对突尼斯家族性高胆固醇血症患者表型变异性的影响。
Atherosclerosis. 2012 May;222(1):158-66. doi: 10.1016/j.atherosclerosis.2012.02.018. Epub 2012 Feb 19.

引用本文的文献

1
Quality of life and its contributors among patients with homozygous familial hypercholesterolemia in China.中国纯合子家族性高胆固醇血症患者的生活质量及其影响因素
Front Public Health. 2025 Aug 27;13:1642895. doi: 10.3389/fpubh.2025.1642895. eCollection 2025.
2
Clinical Management of Dyslipidemia in Infants and Toddlers.婴幼儿血脂异常的临床管理
Curr Atheroscler Rep. 2025 Jun 4;27(1):61. doi: 10.1007/s11883-025-01305-y.
3
Lipoprotein(a) Levels and the Risk of Coronary Heart Disease and Stroke: The Suita Study.脂蛋白(a)水平与冠心病和中风风险:须惠研究
J Atheroscler Thromb. 2025 Sep 1;32(9):1139-1149. doi: 10.5551/jat.65437. Epub 2025 Mar 30.
4
Analysis of low-density lipoprotein receptor gene mutations in a family with familial hypercholesterolemia.家族性高胆固醇血症家系低密度脂蛋白受体基因突变分析。
PLoS One. 2024 Oct 11;19(10):e0310547. doi: 10.1371/journal.pone.0310547. eCollection 2024.
5
A Japanese Case of Familial Hypercholesterolemia with a Protein-truncating Variant in LDLR and a PCSK9 Variant without Significant Atherosclerosis but Showing Remarkable Achilles Tendon Thickening.日本 LDLR 蛋白截断变异和 PCSK9 变异家族性高胆固醇血症病例,无明显动脉粥样硬化但表现出显著的跟腱增厚。
Intern Med. 2024;63(15):2137-2142. doi: 10.2169/internalmedicine.2726-23. Epub 2024 Aug 1.
6
A Japanese Woman with Polygenic Familial Hypercholesteremia Who Exhibited Trivial Atherosclerosis.一名患有多基因家族性高胆固醇血症且有轻微动脉粥样硬化的日本女性。
Intern Med. 2024;63(15):2111-2112. doi: 10.2169/internalmedicine.3089-23. Epub 2024 Aug 1.
7
Prevalence and Clinical Characteristics of Familial Hypercholesterolemia in Patients with Acute Coronary Syndrome according to the Current Japanese Guidelines: Insight from the EXPLORE-J study.根据现行日本指南探讨急性冠脉综合征患者家族性高胆固醇血症的患病率及临床特征:来自EXPLORE-J研究的见解
J Atheroscler Thromb. 2025 Jan 1;32(1):23-33. doi: 10.5551/jat.64972. Epub 2024 Jul 3.
8
Genetic Counseling and Genetic Testing for Familial Hypercholesterolemia.家族性高胆固醇血症的遗传咨询和遗传检测。
Genes (Basel). 2024 Feb 26;15(3):297. doi: 10.3390/genes15030297.
9
Phenotypic homozygous familial hypercholesterolemia successfully treated with proprotein convertase subtilisin/kexin type 9 inhibitors.前蛋白转化酶枯草溶菌素/克新9型抑制剂成功治疗表型纯合子家族性高胆固醇血症
Clin Case Rep. 2024 Feb 19;12(2):e8537. doi: 10.1002/ccr3.8537. eCollection 2024 Feb.
10
Unveiling Familial Hypercholesterolemia-Review, Cardiovascular Complications, Lipid-Lowering Treatment and Its Efficacy.揭示家族性高胆固醇血症——综述、心血管并发症、降脂治疗及其疗效。
Int J Mol Sci. 2024 Jan 29;25(3):1637. doi: 10.3390/ijms25031637.